SAL001 (teriparatide biosimilar) / Shenzhen Salubris - LARVOL DELTA

Biosimilarity Assessment of the Biosimilar Teriparatide Candidate and the Reference Drug in Healthy Subjects. (PubMed, Clin Pharmacol Drug Dev) - "Other PK parameters, serum calcium concentration, and safety profiles had no significant differences between the 2 formulations. SAL001 demonstrated PK similarity to the reference drug, and the serum calcium concentration and safety profiles of SAL001 were also considered comparable to the reference drug."

Journal • Osteoporosis • Rheumatology